Back to Search
AMY FRANKEL, M.D.
M.D.
Dermatology Physician
NPI: 1427293208IndividualAccepts Medicare
Education
OTHER
Class of 2007
Research & Publications (20)
EGFR-targeted diphtheria toxin stimulates TRAIL killing of glioblastoma cells by depleting anti-apoptotic proteins.
PMID 19449148·J Neurooncol·2009
7-preclinical
Anti-CD3 recombinant diphtheria immunotoxin therapy of cutaneous T cell lymphoma.
PMID 19199905·Curr Drug Targets·2009
6-review
Revealing and resolving patient safety defects: the impact of leadership WalkRounds on frontline caregiver assessments of patient safety.
PMID 18671751·Health Serv Res·2008
8-other
Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature.
PMID 17974567·J Biol Chem·2008
7-preclinical
Using the Communication and Teamwork Skills (CATS) Assessment to measure health care team performance.
PMID 17915529·Jt Comm J Qual Patient Saf·2007
8-other
Cosmetic treatments and strategies for the upper face.
PMID 17317553·Facial Plast Surg Clin North Am·2007
6-review
Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia.
PMID 16586495·Cancer·2006
3-trial
Patient Safety Leadership WalkRounds at Partners Healthcare: learning from implementation.
PMID 16156190·Jt Comm J Qual Patient Saf·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 417 SW 117TH AVE STE 100
PORTLAND, OR 97225 - Phone
- (503) 216-8980
Quick Facts
- NPI
- 1427293208
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile